Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Poult Sci ; 92(10): 2644-50, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24046411

RESUMO

In an effort to explore strategies to control Clostridium perfringens, we investigated the synergistic effect of a ubiquitous bacterial second messenger 3',5'-cyclic diguanylic acid (c-di-GMP) with penicillin G in a broiler challenge model. All chicks were inoculated in the crop by gavage on d 14, 15, and 16 with a mixture of 4 C. perfringens strains. Birds were treated with saline (control group) or 20 nmol of c-di-GMP by gavage or intramuscularly (IM) on d 24, all in conjunction with penicillin G in water for 5 d. Weekly samplings of ceca and ileum were performed on d 21 to 35 for C. perfringens and Lactobacillus enumeration. On d 35 of age, the IM treatment significantly (P < 0.05) reduced C. perfringens in the ceca, suggesting possible synergistic activity between penicillin G and c-di-GMP against C. perfringens in broiler ceca. Moreover, analysis of ceca DNA for the presence of a series of C. perfringens virulence genes showed a prevalence of 30% for the Clostridium perfringens alpha-toxin gene (cpa) from d 21 to 35 in the IM-treated group, whereas the occurrence of the cpa gene increased from 10 to 60% in the other 2 groups (control and gavage) from d 21 to 35. Detection of ß-lactamase genes (blaCMY-2, blaSHV, and blaTEM) indicative of gram-negative bacteria in the same samples from d 21 to 35 did not show significant treatment effects. Amplified fragment-length polymorphism showed a predominant 92% similarity between the ceca of 21-d-old control birds and the 35-d-old IM-treated c-di-GMP group. This suggests that c-di-GMP IM treatment might be effective at restoring the normal microflora of the host on d 35 after being challenged by C. perfringens. Our results suggest that c-di-GMP can reduce the colonization of C. perfringens in the gut without increasing the selection pressure for some ß-lactamase genes or altering the commensal bacterial population.


Assuntos
Adjuvantes Imunológicos/farmacologia , Galinhas , Infecções por Clostridium/veterinária , Clostridium perfringens/efeitos dos fármacos , GMP Cíclico/análogos & derivados , Enterite/veterinária , Doenças das Aves Domésticas/imunologia , Adjuvantes Imunológicos/administração & dosagem , Ração Animal/análise , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Ceco/microbiologia , Infecções por Clostridium/tratamento farmacológico , Infecções por Clostridium/imunologia , Clostridium perfringens/patogenicidade , Contagem de Colônia Microbiana/veterinária , GMP Cíclico/administração & dosagem , GMP Cíclico/farmacologia , Nutrição Enteral/veterinária , Enterite/tratamento farmacológico , Enterite/imunologia , Injeções Intramusculares/veterinária , Masculino , Penicilina G/administração & dosagem , Penicilina G/farmacologia , Reação em Cadeia da Polimerase/veterinária , Doenças das Aves Domésticas/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...